closer to home value and high performance one team. Alignment with Implementing Medicines New Zealand This focus area contributes to the following IMNZ impact areas: making the most of every point of care optimal medicines use in older people and those with long-term conditions optimal use of antimicrobial agents. enabling shared care through an integrated health care team competent and responsive prescribers. Actions Lead accountability Priority Ministry of Health Share examples of innovative models of care that can be adopted to support the delivery of medicines management services by pharmacists and pharmacist prescribers. Ministry of Health Ongoing Work to ensure the optimal use of antimicrobial agents. Ministry of Health Ongoing Support a review of regulatory requirements relating to licensed premises to clearly define the requirements that must be met to align with new service delivery models, with a focus on patient safety and privacy. Ministry of Health 2016–17 Facilitate the development of a single prescribing competency framework for all prescribers. Ministry of Health 2016–20 Facilitate discussion with DHBs to explore the development of a national medicines information service. Ministry of Health 2019–20 DHBs Produce annual plans that demonstrate an integrated approach to planning and funding medicines management services. DHBs ongoing Support a collaborative approach to clinical governance at local, regional and national levels. DHBs and PHOs ongoing Ensure new models of care and contractual and governance arrangements enable pharmacist prescribers to initiate relevant laboratory tests. DHBs 2016–18 Ensure models of care and contractual agreements for 2016/17 align with specific targets for implementing medicines adherence and optimisation services and demonstrate a consistent approach to medicines adherence and optimisation across DHBs. DHBs 2016–17 Ensure models of care and contractual agreements provide equitable access to medicines management services targeted towards people receiving risk medicines and/or polypharmacy. DHBs 2017–20 Ensure models of care and contractual agreements provide aged residential care residents with equitable access to medicines management services tailored to the individual’s changing health needs. DHBs 2017–20 Ensure models of care and contractual agreements provide equitable access to medicines management services that support older people and people with complex health needs to live well in their own homes. DHBs 2017–20 Support the integration of pharmacist prescribers into a wide range of primary and secondary care teams. DHBs 2018–20 Sector
prescription has been demonstrated to free up pharmacists to spend more time on providing patient-centred clinical services (NHS Pharmacy Education and Development Committee 2013). Evaluation of a New Zealand pilot indicates similar benefits might be expected in this country. Alignment with the New Zealand Health Strategy This focus area aligns with the following New Zealand Health Strategy key themes: value and high performance smart systems. Alignment with Implementing Medicines New Zealand This focus area contributes to the following IMNZ impact area: making the most of every point of care. Actions Lead accountability Priority Ministry of Health Review the pharmacy audit process to ensure it complies with the Community Pharmacy Services Agreement Audit Strategy 2015–2025. Ministry of Health In progress Review the Health and Disability Services Standards – Pharmacy Services Standard 2010 to enable pharmacies to use PACTs. Ministry of Health 2016–17 Investigate options to drive efficiencies in the medicines supply chain through the broader use of technology, eg, robotic dispensing. Ministry of Health 2016–2019 DHBs Review district need and develop and implement plans to deliver an accessible, sustainable and efficient medicines supply chain, and commission services to meet identified demand. DHBs 2016–19 Support systems to reduce prescribing and prescription errors and minimise pharmaceutical waste in aged care and other residential facilities. DHBs 2016–19 Sector Develop best-practice guidelines for dispensing. For example, ensure that a pharmacist clinically screens every prescription before it is dispensed. Pharmaceutical Society of New Zealand (PSNZ) and Pharmacy Council of New Zealand (PCNZ) jointly 2016–18 Promote a culture of open disclosure to support continuous improvement and decrease the incidence of dispensing errors. PCNZ 2016–18 Consider all relevant supply chain factors (eg, pack size, wastage, appropriate distribution for high-cost medicines) in making decisions about funded medicines (and how such medicines are prescribed, distributed and dispensed). PHARMAC 2016–18 Engage in high-quality communication about the implications of decisions for the supply chain, including factors considered. PHARMAC 2016–18 All actions in this Plan may change with any future changes in priorities, costing and funding over the five-year period it covers.